Skip to main content
Top
Published in: International Urology and Nephrology 9/2017

01-09-2017 | Urology - Original Paper

Effects of long-term treatment with haloperidol, clozapine and aripiprazole on mice isolated vas deferens

Authors: Mehmet Hanifi Tanyeri, Mehmet Emin Buyukokuroglu, Pelin Tanyeri, Oguz Mutlu, Füruzan Yildiz Akar, Güner Ulak, Bekir Faruk Erden

Published in: International Urology and Nephrology | Issue 9/2017

Login to get access

Abstract

Purpose

Sexual dysfunction is a common condition in patients taking antipsychotics and is the most bothersome symptom and adverse drug effect, resulting in a negative effect on treatment compliance. Pharmacology research into human ejeculatory disorders is limited to clinical studies with registered drugs affecting the ejaculation process; therefore, animal research has become the need. We aimed to investigate the effects of haloperidol, clozapine and aripiprazole on serotonin, noradrenaline, adenosine triphosphate (ATP) and potassium chloride (KCl)-induced contractions of the vas deferens in order to evaluate the effect of haloperidol, clozapine and aripiprazole on the contraction of the vas deferens.

Methods

Male inbred BALB/c ByJ mice aged 7 weeks upon arrival to the laboratory were used in this study. Haloperidol, clozapine, aripiprazole, serotonin, noradrenaline, ATP and KCl were dissolved in 0.9% physiological saline. The mice were randomly divided into experimental groups as follows: saline; haloperidol 0.125 mg/kg; haloperidol 0.25 mg/kg; clozapine 1.25 mg/kg; clozapine 2.5 mg/kg; aripiprazole 3 mg/kg; aripiprazole 6 mg/kg. Mice were treated by ip injection of drugs during 21 days. Mice receiving only the vehicle ip (0.9% saline) during 21 days served as control group (n = 7). Each experimental group consisted of 7 mice. After 21 days of treatment, epididymal and prostatic portions of vas deferens were surgically dissected free and immersed in 20-mL organ baths containing Krebs’ solution. The effects of chronic treatment with haloperidol (0.125 and 0.25 mg/kg), clozapine(1.25 and 2.5 mg/kg) and aripiprazole (3 and 6 mg/kg) were investigated on serotonin [10 (−8) to 10 (−4) M], noradrenaline [10 (−8) to 10 (−4) M], ATP [10 (−8) to 10 (−4) M] and 80 mM KCl-induced contractile responses in the epididymal and prostatic portions of mice isolated vas deferens strips. Statistical comparison between the groups was performed using ANOVA supported by Dunnett’s post hoc test.

Results

Serotonin-induced contractile responses were significantly increased in the epididymal and prostatic portions of the vas deferens obtained from the haloperidol-treated group and clozapine-treated group. However, aripiprazole treatment had no effect on serotonin responses in both epididymal and prostatic portions of mice vas deferens. On the other hand, haloperidol and clozapine treatments significantly inhibited both noradrenaline and ATP-induced contractions of the prostatic and epididymal portions of the mice vas deferens, but had no effect on KCl-induced contractions of the vas deferens in both portions. There were no significant differences in KCl-induced contractile responses among the groups.

Conclusions

These results revealed that induced contractions of vas deferens were affected after chronic treatment with haloperidol and clozapine but not aripiprazole. Serotonergic, noradrenergic and purinergic receptors may, at least in part, contribute to changes in vas deferens contractions in mice with chronic treatment of haloperidol and clozapine but not aripiprazole.
Literature
2.
go back to reference Montejo AL, Montejo L, Navarro-Cremades F (2015) Sexual side-effects of antidepressant and antipsychotic drugs. Curr Opin Psychiatry 28(6):418–423CrossRefPubMed Montejo AL, Montejo L, Navarro-Cremades F (2015) Sexual side-effects of antidepressant and antipsychotic drugs. Curr Opin Psychiatry 28(6):418–423CrossRefPubMed
3.
4.
go back to reference Smith SM, O’Keane V, Murray R (2002) Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 181:49–55CrossRefPubMed Smith SM, O’Keane V, Murray R (2002) Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 181:49–55CrossRefPubMed
5.
go back to reference Haddad PM, Wieck A (2004) Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 64:2291–2314CrossRefPubMed Haddad PM, Wieck A (2004) Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 64:2291–2314CrossRefPubMed
7.
go back to reference Knegtering H, van der Moolen AE, Castelein S, Kluiter H, van den Bosch RJ (2003) What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology 28(Suppl 2):109–123CrossRefPubMed Knegtering H, van der Moolen AE, Castelein S, Kluiter H, van den Bosch RJ (2003) What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology 28(Suppl 2):109–123CrossRefPubMed
8.
go back to reference Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A et al (2006) Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 21:251–258CrossRefPubMed Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A et al (2006) Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 21:251–258CrossRefPubMed
9.
go back to reference Aizenberg D, Modai I, Landa A, Gil-Ad I, Weizman A (2001) Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine. J Clin Psychiatry 62:541–544CrossRefPubMed Aizenberg D, Modai I, Landa A, Gil-Ad I, Weizman A (2001) Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine. J Clin Psychiatry 62:541–544CrossRefPubMed
10.
go back to reference Mullen B, Brar JS, Vagnucci AH, Ganguli R (2001) Frequency of sexual dysfunctions in patients with schizophrenia on haloperidol, clozapine or risperidone. Schizophr Res 48:155–158CrossRefPubMed Mullen B, Brar JS, Vagnucci AH, Ganguli R (2001) Frequency of sexual dysfunctions in patients with schizophrenia on haloperidol, clozapine or risperidone. Schizophr Res 48:155–158CrossRefPubMed
11.
go back to reference Baggaley M (2008) Sexual dysfunction in schizophrenia: focus on recent evidence. Hum Psychopharmacol 23:201–209CrossRefPubMed Baggaley M (2008) Sexual dysfunction in schizophrenia: focus on recent evidence. Hum Psychopharmacol 23:201–209CrossRefPubMed
12.
go back to reference Hanssens L, L’Italien G, Loze JY, Marcus RN, Pans M, Kerselaers W (2008) The effect of antipsychotic medication on sexual function and serum prolactin levels in community- treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). BMC Psychiatry 8:95CrossRefPubMedPubMedCentral Hanssens L, L’Italien G, Loze JY, Marcus RN, Pans M, Kerselaers W (2008) The effect of antipsychotic medication on sexual function and serum prolactin levels in community- treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). BMC Psychiatry 8:95CrossRefPubMedPubMedCentral
13.
go back to reference Mir A, Shivakumar K, Williamson RJ, McAllister V, O’Keane V, Aitchison KJ (2008) Change in sexual dysfunction with aripiprazole: a switching or add-on study. J Psychopharmacol 22:244–253CrossRefPubMed Mir A, Shivakumar K, Williamson RJ, McAllister V, O’Keane V, Aitchison KJ (2008) Change in sexual dysfunction with aripiprazole: a switching or add-on study. J Psychopharmacol 22:244–253CrossRefPubMed
14.
16.
go back to reference Ralph DJ, Wylie KR (2005) Ejaculatory disorders and sexual function. BJU Int 95(9):1181–1186 (Review) CrossRefPubMed Ralph DJ, Wylie KR (2005) Ejaculatory disorders and sexual function. BJU Int 95(9):1181–1186 (Review) CrossRefPubMed
17.
go back to reference Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ (2000) Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403(6765):86–89CrossRefPubMed Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ (2000) Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403(6765):86–89CrossRefPubMed
18.
go back to reference Tanyeri P, Buyukokuroglu ME, Mutlu O, Ulak G, Akar FY, Celikyurt IK, Erden BF (2013) Evidence that the anxiolytic-like effects of the beta3 receptor agonist amibegron involve serotoninergic receptor activity. Pharmacol Biochem Behav 110:27–32. doi:10.1016/j.pbb.2013.05.017 CrossRefPubMed Tanyeri P, Buyukokuroglu ME, Mutlu O, Ulak G, Akar FY, Celikyurt IK, Erden BF (2013) Evidence that the anxiolytic-like effects of the beta3 receptor agonist amibegron involve serotoninergic receptor activity. Pharmacol Biochem Behav 110:27–32. doi:10.​1016/​j.​pbb.​2013.​05.​017 CrossRefPubMed
19.
go back to reference Tanyeri P, Buyukokuroglu ME, Mutlu O, Ulak G, Yıldız Akar F, Komsuoglu Celikyurt I, Erden BF (2013) Involvement of serotonin receptor subtypes in the antidepressant-like effect of beta receptor agonist Amibegron (SR 58611A): an experimental study. Pharmacol Biochem Behav 105:12–16. doi:10.1016/j.pbb.2013.01.010 CrossRefPubMed Tanyeri P, Buyukokuroglu ME, Mutlu O, Ulak G, Yıldız Akar F, Komsuoglu Celikyurt I, Erden BF (2013) Involvement of serotonin receptor subtypes in the antidepressant-like effect of beta receptor agonist Amibegron (SR 58611A): an experimental study. Pharmacol Biochem Behav 105:12–16. doi:10.​1016/​j.​pbb.​2013.​01.​010 CrossRefPubMed
20.
go back to reference Ventura S (1998) Autoinhibition, sympathetic cotransmission and biphasic contractile responses to trains of nerve stimulation in the rodent vas deferens. Clin Exp Pharmacol Physiol 25(12):965–973 (Review) CrossRefPubMed Ventura S (1998) Autoinhibition, sympathetic cotransmission and biphasic contractile responses to trains of nerve stimulation in the rodent vas deferens. Clin Exp Pharmacol Physiol 25(12):965–973 (Review) CrossRefPubMed
21.
go back to reference Munhall JP, Hsiao W (2014) Men’s sexual health and fertility: a clinican’s guide. Springer, Berlin. XIII, 268 p. 13 illus, 9 illus, in color, hardcover Munhall JP, Hsiao W (2014) Men’s sexual health and fertility: a clinican’s guide. Springer, Berlin. XIII, 268 p. 13 illus, 9 illus, in color, hardcover
22.
go back to reference Coolen LM, Peters HJ, Veening JG (1996) Fos immunoreactivity in the rat brain following consummatory elements of sexual behavior: a sex comparison. Brain Res 738(1):67–82CrossRefPubMed Coolen LM, Peters HJ, Veening JG (1996) Fos immunoreactivity in the rat brain following consummatory elements of sexual behavior: a sex comparison. Brain Res 738(1):67–82CrossRefPubMed
23.
24.
go back to reference Peeters M, Giuliano F (2008) Central neurophysiology and dopaminergic control of ejaculation. Neurosci Biobehav Rev 32(3):438–453CrossRefPubMed Peeters M, Giuliano F (2008) Central neurophysiology and dopaminergic control of ejaculation. Neurosci Biobehav Rev 32(3):438–453CrossRefPubMed
25.
go back to reference Sato Y, Horita H, Kurohata T, Adachi H, Tsukamoto T (1998) Effect of the nitric oxide level in the medial preoptic area on male copulatory behavior in rats. Am J Physiol 274(1 Pt 2):R243–R247PubMed Sato Y, Horita H, Kurohata T, Adachi H, Tsukamoto T (1998) Effect of the nitric oxide level in the medial preoptic area on male copulatory behavior in rats. Am J Physiol 274(1 Pt 2):R243–R247PubMed
26.
go back to reference Boselli C, Bianchi L, Barbieri A, Grana E (1998) Effect of calcium antagonists on the response to noradrenaline in the whole and bisected rat vas deferens. J Auton Pharmacol 18(5):297–306CrossRefPubMed Boselli C, Bianchi L, Barbieri A, Grana E (1998) Effect of calcium antagonists on the response to noradrenaline in the whole and bisected rat vas deferens. J Auton Pharmacol 18(5):297–306CrossRefPubMed
27.
go back to reference Yells DP, Prendergast MA, Hendricks SE, Nakamura M (1994) Fluoxetine-induced inhibition of male rat copulatory behavior: modification by lesions of the nucleus paragigantocellularis. Pharmacol Biochem Behav 49(1):121–127CrossRefPubMed Yells DP, Prendergast MA, Hendricks SE, Nakamura M (1994) Fluoxetine-induced inhibition of male rat copulatory behavior: modification by lesions of the nucleus paragigantocellularis. Pharmacol Biochem Behav 49(1):121–127CrossRefPubMed
28.
go back to reference Zajecka J, Fawcett J, Schaff M, Jeffriess H, Guy C (1991) The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction. J Clin Psychiatry 52(2):66–68PubMed Zajecka J, Fawcett J, Schaff M, Jeffriess H, Guy C (1991) The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction. J Clin Psychiatry 52(2):66–68PubMed
29.
go back to reference Busch L, Wald M, Borda E (1999) Long-term treatment with fluoxetine associates with peripheral effects on rat vas deferens contractility. Life Sci 64(10):PL117–PL123CrossRefPubMed Busch L, Wald M, Borda E (1999) Long-term treatment with fluoxetine associates with peripheral effects on rat vas deferens contractility. Life Sci 64(10):PL117–PL123CrossRefPubMed
30.
go back to reference de Jong TR, Pattij T, Veening JG, Dederen PJ, Waldinger MD, Cools AR, Olivier B (2005) Effects of chronic paroxetine pretreatment on (±)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior. Neuroscience 134(4):1351–1361CrossRefPubMed de Jong TR, Pattij T, Veening JG, Dederen PJ, Waldinger MD, Cools AR, Olivier B (2005) Effects of chronic paroxetine pretreatment on (±)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior. Neuroscience 134(4):1351–1361CrossRefPubMed
31.
go back to reference Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B (1998) Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 18(4):274–281CrossRefPubMed Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B (1998) Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 18(4):274–281CrossRefPubMed
32.
go back to reference Waldinger MD, Olivier B (2005) Animal models of premature and retarded ejaculation. World J Urol 23(2):115–118CrossRefPubMed Waldinger MD, Olivier B (2005) Animal models of premature and retarded ejaculation. World J Urol 23(2):115–118CrossRefPubMed
33.
go back to reference Deshpande SB (1993) Potentiation of serotonin-induced contractility of gastric fundus strips in lactating rats. Acta Physiol Scand 149(1):51–57CrossRefPubMed Deshpande SB (1993) Potentiation of serotonin-induced contractility of gastric fundus strips in lactating rats. Acta Physiol Scand 149(1):51–57CrossRefPubMed
34.
go back to reference Sneddon P, Machaly M (1992) Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea-pig. J Auton Pharmacol 12(6):421–428CrossRefPubMed Sneddon P, Machaly M (1992) Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea-pig. J Auton Pharmacol 12(6):421–428CrossRefPubMed
Metadata
Title
Effects of long-term treatment with haloperidol, clozapine and aripiprazole on mice isolated vas deferens
Authors
Mehmet Hanifi Tanyeri
Mehmet Emin Buyukokuroglu
Pelin Tanyeri
Oguz Mutlu
Füruzan Yildiz Akar
Güner Ulak
Bekir Faruk Erden
Publication date
01-09-2017
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 9/2017
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1640-9

Other articles of this Issue 9/2017

International Urology and Nephrology 9/2017 Go to the issue